… the risk of pneumonia with the inhaled corticosteroids currently available (fluticasone and
budesonide). Evidence for any intraclass differences in the risk … Inhaled corticosteroids have no …

… This study was undertaken to quantify the risk of cataract associated with the use of inhaled
… of inhaled corticosteroids used for prolonged periods are associated with an increased risk …

… Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:580–584. …

Background: Several clinical trials have evaluated the benefits associated with adding an
inhaled corticosteroid (ICS) to a long-acting bronchodilator in the treatment of severe or very …

… Due to heterogeneity in the reporting of serious adverse events across the studies, we do
not know whether inhaled corticosteroids increase or decrease the risk of this outcome. There …

… how inhaled corticosteroids work in asthma, and much more data on the efficacy and safety
of inhaled corticosteroids … with inhaled corticosteroids may reduce the risk of undertreatment. …

… that inhaled corticosteroids are not efficacious in preventing a first exacerbation of chronic
obstructive pulmonary disease. The small increase in risk is … benefit of inhaled corticosteroids. …

… -α agents increase the risk of TB. However, little is known about whether inhaled corticosteroid
(ICS) increases the risk of TB. We performed this study to assess the risk of pulmonary TB …

… of COPD patients to whom inhaled corticosteroids (ICSs) were … the risk for hospital readmission
or death is high and therapy with ICSs might be expected to be administered to high-risk …

… efficacy and safety of inhaled corticosteroids in the management of … relative potencies of
the various inhaled corticosteroids. … , the existing inhaled corticosteroids have similar risks of …